Down Syndrome – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

 Down Syndrome is a chromosomal disease characterized by intellectual disability, a distinctive facial appearance, and low muscle tone (hypotonia) in infancy. Although all affected people experience cognitive delays, the intellectual disability is usually mild to moderate. People with DS may have a variety of congenital disabilities. A heart defect affects approximately half of all affected children. Digestive abnormalities, such as intestine blockage, are less common. Individuals with DS are at a higher risk of developing various medical conditions. These include gastroesophageal reflux, a backflow of acidic stomach contents into the esophagus, and celiac disease, a gluten intolerance. Trisomy 21 (nondisjunction) is the most ordinary type of Down syndrome, accounting for 95 percent of cases. Babies are typically born with 23 chromosome pairs (or 46 total chromosomes) in each cell, one inherited from the mother and father. In Trisomy 21, an error in cell division is called “nondisjunction” this results in a baby being born with an additional copy of chromosome 21, meaning there are three copies of chromosome 21 instead of the usual two.

·       The prevalence of Down Syndrome ranges from 80 to 91 cases per 100,000 population in the USA.

 

Thelansis’s “Down Syndrome Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Down Syndrome treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

 

KOLs insights of Down Syndrome across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Down Syndrome Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Down Syndrome – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Tags: Down Syndrome, Down Syndrome market outlook, Down Syndrome competitive landscape, Down Syndrome market forecast, Thelansis, Primary market research, KOL insights, Competitive Intelligence (CI)